Laos government pledges justice in mass alcohol poisoning case that has killed 6 tourists
Fighting between armed sectarian groups in restive northwestern Pakistan kills at least 33 people
Key UN committee adopts resolution paving the way for a first-ever treaty on crimes against humanity
IMF approves third review of Sri Lanka's $2.9 billion bailout
Wealthy countries back raising COP29 climate deal to $300 billion, sources say
Adani CFO says US charges linked to only one business contract
Jai'Den Thomas leads No. 23 UNLV to a 27-16 victory over San Jose State
Austin Hays, Kyle Finnegan, Brendan Rodgers and Jordan Romano among 62 new free agents
WASHINGTON (Reuters) - The U.S. House of Representatives oversight panel said on Tuesday it will hold a hearing with executives from U.S. pharmacy benefit managers on the role of the firms in rising healthcare costs.
The hearing will include Adam Kautzner, president of Evernorth Care Management and Express Scripts; David Joyner, executive vice president of CVS Health and president of CVS Caremark; and Patrick Conway, CEO of OptumRx, the panel's chair, Representative James Comer, a Republican, said in a statement.
The hearing is set for July 23.
(Reporting by Kanishka Singh and Jasper Ward in Washington; Editing by Leslie Adler)
